Tissue / Organ-On-A-Chip
Recent progress in microchip and tissue engineering technologies are paving the way to the development of micro-physiological systems which can emulate the biological processes and functions of the human physiology. These systems aim to model various diseases, stages of disease development, toxicity, immunogenicity, as well as leading to the generation of accurate ADME profiles for the development of safe and effective drug candidates before clinical evaluation. MPSs are expected to change the perspectives in disease modelling/drug development, personalized medicine, regenerative medicine and stem cells; thus Biovalda, Inc. has ongoing R&D studies on the microfluidic in-vitro tissue and tissue interface models.
For detailed information:
“Special Issue: Organs-on-Chips & 3D–Bioprinting Technologies for Personalized Medicine (Editorial Note)”
STEM CELL REVIEWS AND REPORTS, 13(3), 319-320 (2017)